This brief reviews regulatory guidance documents and how they may apply to multi-purpose technologies (MPTs). It examines guidance documents from the Food and Drug Administration (FDA), the European Medicines Agency (EMA) and the International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH). The brief concludes by anticipating increased interactions with US regulatory agencies in hopes of finding new regulatory pathways that address MPTs specifically.
Brady, Martha and Heeyoung Park. 2011. "What regulatory guidance exists for multipurpose prevention technologies (MPTs)? A review of key guidance documents and their applicability to MPTs." Washington, DC: Population Council.
Health Policy Commons, Health Services Research Commons, Immune System Diseases Commons, International Public Health Commons, Medicine and Health Commons, Virus Diseases Commons, Women's Health Commons